Frontlight ResearchEarly access
Hepatitis B trials in United Kingdom
2 of 5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in United KingdomStudy of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- Where
- London
- Age
- 18 years to 65 years
- People
- 70 worldwide
- Run by
- AusperBio Therapeutics Inc.
See details and how to joinNCT07654283 · EU 2025-524159-30-00 - Phase 1/2Taking peopleA Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
- Where
- London
- Age
- 18 years to 64 years
- People
- 66 worldwide
- Run by
- nChroma Bio
See details and how to joinNCT07200193 · EU 2025-523619-12-00